Back to mobile site

Exact Sciences (EXAS) Misses Q1 EPS by 21c, Updates Guidance

May 1, 2025 4:24 PM EDT

Exact Sciences (NASDAQ: EXAS) reported Q1 EPS of ($0.54), $0.21 worse than the analyst estimate of ($0.33). Revenue for the quarter came in at $707 million versus the consensus estimate of $688.78 million.

GUIDANCE:

Exact Sciences sees FY2025 revenue of $3.07-3.12 billion, versus the consensus of $3.9 billion.

For earnings history and earnings-related data on Exact Sciences (EXAS) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings, Maynard Um, Mark Zuckerberg, ARK